These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16893644)

  • 1. Determination of androgen bioactivity in human serum samples using a recombinant cell based in vitro bioassay.
    Roy P; Franks S; Read M; Huhtaniemi IT
    J Steroid Biochem Mol Biol; 2006 Sep; 101(1):68-77. PubMed ID: 16893644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay.
    Roy P; Salminen H; Koskimies P; Simola J; Smeds A; Saukko P; Huhtaniemi IT
    J Steroid Biochem Mol Biol; 2004 Feb; 88(2):157-66. PubMed ID: 15084347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
    Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
    Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel assay for determination of androgen bioactivity in human serum.
    Raivio T; Palvimo JJ; Dunkel L; Wickman S; Jänne OA
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1539-44. PubMed ID: 11297580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists.
    Wilson VS; Bobseine K; Lambright CR; Gray LE
    Toxicol Sci; 2002 Mar; 66(1):69-81. PubMed ID: 11861974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel cell based androgen screening model.
    Campana C; Rege J; Turcu AF; Pezzi V; Gomez-Sanchez CE; Robins DM; Rainey WE
    J Steroid Biochem Mol Biol; 2016 Feb; 156():17-22. PubMed ID: 26581480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of androgenic bioactivity in human serum by recombinant cell line: preliminary results.
    Paris F; Servant N; Térouanne B; Sultan C
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):123-9. PubMed ID: 12573822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an androgen reporter gene assay (AR-LUX) utilizing a human cell line with an endogenously regulated androgen receptor.
    Blankvoort BM; de Groene EM; van Meeteren-Kreikamp AP; Witkamp RF; Rodenburg RJ; Aarts JM
    Anal Biochem; 2001 Nov; 298(1):93-102. PubMed ID: 11673900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
    Paris F; Rabeolina F; Balaguer P; Bacquet A; Sultan C
    Gynecol Endocrinol; 2007 Apr; 23(4):193-7. PubMed ID: 17505938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context.
    Simon S; Mueller SO
    Toxicology; 2006 Mar; 220(2-3):90-103. PubMed ID: 16413649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection with steroid-responsive reporter constructs shows glucocorticoid rather than androgen responsiveness in cultured Sertoli cells.
    Denolet E; Gendt KD; Swinnen JV; Verrijdt G; Deboel L; Roskams T; Verhoeven G
    J Steroid Biochem Mol Biol; 2006 Feb; 98(2-3):164-73. PubMed ID: 16388947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive in vitro test systems to determine androgenic/antiandrogenic activity.
    Guth SE; Böhm S; Mussler BH; Eisenbrand G
    Mol Nutr Food Res; 2004 Sep; 48(4):282-91. PubMed ID: 15497179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of androgenic activity of nutraceutical-derived steroids using mammalian and yeast in vitro androgen bioassays.
    Akram ON; Bursill C; Desai R; Heather AK; Kazlauskas R; Handelsman DJ; Lambert G
    Anal Chem; 2011 Mar; 83(6):2065-74. PubMed ID: 21329390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects.
    Térouanne B; Tahiri B; Georget V; Belon C; Poujol N; Avances C; Orio F; Balaguer P; Sultan C
    Mol Cell Endocrinol; 2000 Feb; 160(1-2):39-49. PubMed ID: 10715537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating bioactive androgens in midlife women.
    Chen J; Sowers MR; Moran FM; McConnell DS; Gee NA; Greendale GA; Whitehead C; Kasim-Karakas SE; Lasley BL
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4387-94. PubMed ID: 16940455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new recombinant cell-based bioluminescent assay for sensitive androgen-like compound detection.
    Michelini E; Leskinen P; Virta M; Karp M; Roda A
    Biosens Bioelectron; 2005 May; 20(11):2261-7. PubMed ID: 15797324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of steroid hormones and antihormones in cultured cells.
    Jung-Testas I; Baulieu EE
    Exp Clin Endocrinol; 1985 Dec; 86(2):151-64. PubMed ID: 2936615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of anabolic steroid abuse using a yeast transactivation system.
    Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
    Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum androgen bioactivity during 5alpha-dihydrotestosterone treatment in elderly men.
    Raivio T; Tapanainen JS; Kunelius P; Jänne OA
    J Androl; 2002; 23(6):919-21. PubMed ID: 12399539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.